Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.280
+0.010 (0.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cabaletta Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
64111973270107300
Upgrade
Market Cap Growth
-88.59%-88.59%260.85%151.03%-64.23%-10.59%
Upgrade
Enterprise Value
-84-57813184-12183
Upgrade
Last Close Price
1.272.2722.709.253.7912.48
Upgrade
PB Ratio
0.420.734.122.580.912.74
Upgrade
P/TBV Ratio
0.420.734.122.580.912.74
Upgrade
Debt / Equity Ratio
0.100.100.020.05--
Upgrade
Quick Ratio
6.056.0515.0811.2314.5920.98
Upgrade
Current Ratio
6.156.1515.2911.4714.8621.92
Upgrade
Return on Equity (ROE)
-59.64%-59.64%-39.73%-47.62%-40.69%-26.90%
Upgrade
Return on Assets (ROA)
-35.66%-35.66%-25.18%-27.81%-24.02%-16.51%
Upgrade
Return on Capital (ROIC)
-38.23%-38.23%-26.60%-29.73%-25.45%-17.06%
Upgrade
Earnings Yield
-179.79%-104.43%-6.96%-19.65%-43.11%-11.11%
Upgrade
FCF Yield
-140.33%-81.51%-5.58%-18.12%-32.85%-9.13%
Upgrade
Buyback Yield / Dilution
-19.77%-19.77%-39.54%-14.01%-11.20%-323.18%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q